ANCOBON PRESCRIBING INFORMATION PDF

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Gardashura Kizragore
Country: Bermuda
Language: English (Spanish)
Genre: Music
Published (Last): 11 October 2006
Pages: 237
PDF File Size: 10.5 Mb
ePub File Size: 13.23 Mb
ISBN: 833-8-54380-469-6
Downloads: 40995
Price: Free* [*Free Regsitration Required]
Uploader: Banris

Amphotericin B liposomal LAmB: The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Flucytosine. Breastfeeding is contraindicated during flucytosine treatment see section 4.

The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flucytosine. Infformation risk or severity of adverse effects can be increased when Flucytosine is combined with Acteoside. Fluorouracil The risk or severity of adverse effects can be increased when Fluorouracil is combined with Flucytosine. Flucytosine should only be used during pregnancy when the potential benefits justify the possible risks to the foetus.

As a rule, treatment with Ancotil for Infusion should rarely be required for periods of more than one week. The therapeutic efficacy of Rotavirus Vaccine can be decreased prescribint used in combination with Flucytosine. Palbociclib The risk or severity of adverse effects can be increased when Flucytosine is combined with Palbociclib. As fluorouracil is a metabolite of flucytosine, concomitant administration of these drugs with Ancotil is contraindicated see section 4.

  ELIZABETH AMBER SEVIN PDF

The risk or severity of adverse effects can be increased when Flucytosine is combined with Paclitaxel. Flunisolide The risk or severity of adverse effects can be increased when Flunisolide is combined with Flucytosine. Dexamethasone The risk or severity of adverse effects can be increased when Flucytosine is combined with Dexamethasone.

The duration of treatment should be determined on an individual basis. Paramethasone The risk or severity of adverse effects can be increased when Flucytosine is combined with Paramethasone. The risk or severity of adverse effects ahcobon be increased when Pemetrexed is combined with Flucytosine.

Cyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Flucytosine. It is excreted mainly unchanged via the kidneys.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Dexamethasone.

Ancotil 2.5g/250ml Solution for Infusion

Beclomethasone dipropionate The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Flucytosine. No unexpected adverse prescriing occurred.

Bemiparin The risk or severity of bleeding can be increased when Bemiparin is combined with Flucytosine. The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Flucytosine.

WHO Model Prescribing Information: Drugs Used in HIV-Related Infections: Drugs: Flucytosine

In humans, flucytosine crosses the placenta. Where renal impairment is not a feature but serum levels are above those recommended, the dose should be reduced but the dosing interval should remain the same.

  KNUCKLEBONES RULES PDF

The risk or severity of bleeding can be increased when Hydroxytyrosol ancobbon combined with Flucytosine. This combination may allow for a reduction in the total daily dose of amphotericin B.

Flucytosine

Fluocortin The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluocortin. Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Flucytosine.

In isolated cases, bone marrow toxicity may be irreversible and could lead to death in patients with pre-existing immuno-suppression, Local irritation or phlebitis does not appear to be a problem with Ancotil for Infusion.

The therapeutic efficacy of Palifermin can presribing decreased when used in combination with Flucytosine. Infusion bottles containing 2. The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Flucytosine. Navigation menu Personal tools Create account Log in.

Phenprocoumon The risk or severity of bleeding can be increased when Presctibing is combined with Phenprocoumon. The therapeutic efficacy of Typhoid Vaccine Live Ty21a can be decreased when used in combination with Flucytosine.

Ancotil for Infusion may be given concurrently with other infusions of Sodium Chloride Intravenous infusion 0.